MENU

Pfizer agrees to invest more than $95M to buy stake in French vaccines company Valneva

Pfizer agreed to invest $95.24 million to buy an 8% percent stake in French vaccine company Valneva as the two companies work to stop Lyme disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story